Pneumonia (peds): Difference between revisions

No edit summary
Line 47: Line 47:


== Treatment<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==
== Treatment<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==
===Newborn===
{{Pediatric pneumonia treatment}}
*Hospitalized
**[[Ampicillin]] (80-90mg/kg/day) + [[gentamicin]] +/- [[cefotaxime]]
***Add [[vancomycin]] if [[MRSA]] a concern
***Add [[erythromycin]] (12.g mg/kg QID) if concern for [[chlamydia]]
*Outpatient
**Initial outpatient management not recommended
 
===1-3 Month===
*Hospitalized
**Afebrile pneumonitis
***[[Erythromycin]] (10 mg/kg q6) or [[azithro]] (2.5 mg/kg q12)
**Febrile pneumonia
*Add [[cefoTAXime]] (200mg/kg per day divided q8h)
*Outpatient
**[[erythromycin]] OR [[azithro]] PO
 
===>3mo - 18 years===
*Hospitalized
**Fully immunized:  [[Ampicillin]] (50mg/kg q6) IV
**Not fully immunized: [[cefoTAXime]] (150 mg/kg divided q8h) IV
*Outpatient
**[[Amoxicillin]] (90 mg/kg divided BID) x 5 days PO
**Alternative: [[azithromycin]] OR [[amoxicillin-clavulanate]]


==Disposition==
==Disposition==

Revision as of 22:24, 26 May 2015

Background

  • Most common site of infection in neonates
  • Fever and tachypnea are sensitive but not specific

Bugs by Age Group

Clinical Features

Differential Diagnosis

Diagnosis

  • Absence of tachypnea, resp distress, and rales/decr BS rules-out with 100% sp
    • Productive cough is rarely seen before late childhood
  • Imaging
    • CXR is not the gold standard!
    • Cannot differentiate between viral and bact (but lobar infiltrate more often bacterial)
    • Consider for:
      • Age 0-3mo (part of w/u for sepsis)
      • <5yr w/ temp >102.2, WBC >20K and no clear source of infection
      • Ambiguous clinical findings
      • PNA that is prolonged or not responsive to abx
  • Consider rapid assays for RSV, influenza
  • Blood/nasal culture are low yield

Treatment[1]

Newborn

1-3 Month

>3mo - 18 years

Disposition

  • All Children less than 2 months should be hospitalized[16]
  • Consider admission for:
    • Age of birth to 3mo
    • History of severe or relevant congenital disorders
    • Immune suppression (HIV, SCD, malignancy)
    • Toxic appearance/resp distress
    • SpO2 <90-93%

See Also

Source

  1. Sanford Guide to Antimicrobial Therapy 2014
  2. Sanford Guide to Antimicrobial Therapy 2014
  3. Sanford Guide to Antimicrobial Therapy 2014
  4. Sanford Guide to Antimicrobial Therapy 2014
  5. Sanford Guide to Antimicrobial Therapy 2014
  6. Harbor-UCLA ID Guidelines 2026
  7. Sanford Guide to Antimicrobial Therapy 2014
  8. Harbor-UCLA ID Guidelines 2026
  9. Harbor-UCLA ID Guidelines 2026
  10. Sanford Guide to Antimicrobial Therapy 2014
  11. Harbor-UCLA ID Guidelines 2026
  12. Sanford Guide to Antimicrobial Therapy 2014
  13. Harbor-UCLA ID Guidelines 2026
  14. Sanford Guide to Antimicrobial Therapy 2014
  15. Harbor-UCLA ID Guidelines 2026
  16. AAP. Management of Communty-Acquired Pneumonia in Infants and Children Older than 3 Months of Age. Pediatrics. Vol 128 No 6 December 1, 2011